Analyzing Ocugen (NASDAQ:OCGN) & Allied Healthcare Products (NASDAQ:AHPI)

Ocugen (NASDAQ:OCGN) and Allied Healthcare Products (NASDAQ:AHPI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Insider & Institutional Ownership

6.7% of Ocugen shares are held by institutional investors. Comparatively, 11.2% of Allied Healthcare Products shares are held by institutional investors. 44.7% of Ocugen shares are held by insiders. Comparatively, 44.9% of Allied Healthcare Products shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk and Volatility

Ocugen has a beta of 2.64, indicating that its stock price is 164% more volatile than the S&P 500. Comparatively, Allied Healthcare Products has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for Ocugen and Allied Healthcare Products, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ocugen 0 0 1 0 3.00
Allied Healthcare Products 0 0 0 0 N/A

Ocugen currently has a consensus price target of $2.00, indicating a potential upside of 354.55%. Given Ocugen’s higher probable upside, analysts clearly believe Ocugen is more favorable than Allied Healthcare Products.

Earnings and Valuation

This table compares Ocugen and Allied Healthcare Products’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ocugen N/A N/A -$8.64 million N/A N/A
Allied Healthcare Products $31.38 million 0.14 -$2.11 million N/A N/A

Allied Healthcare Products has higher revenue and earnings than Ocugen.

Profitability

This table compares Ocugen and Allied Healthcare Products’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ocugen N/A -243.39% -0.45%
Allied Healthcare Products -4.64% -17.53% -12.93%

About Ocugen

Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. The company offers an ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules, as well as targets a range of retinal and ocular surface diseases. Its pipeline includes OCU400 and OCU410 for the treatment of inherited retinal disorders; OCU200 for the treatment of wet-AMD, DME, and diabetic retinopathy; OCU100 for retinitis pigmentosa; and OCU300, which is in Phase III clinical trial for the treatment of ocular graft versus host diseases. The company based in Malvern, Pennsylvania.

About Allied Healthcare Products

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company's respiratory care/anesthesia products comprise air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products include aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, and portable suction equipment. It also provides medical gas equipment, which comprise construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers medical products that include respiratory/resuscitation products comprising demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products, such as spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. Allied Healthcare Products, Inc. was founded in 1979 and is headquartered in St. Louis, Missouri.

Receive News & Ratings for Ocugen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ocugen and related companies with MarketBeat.com's FREE daily email newsletter.